(Washington, D.C.) — As independent drugstore lobbyists descend on Harrisburg for their lobby day, the Pharmaceutical Care Management Association (PCMA) released the following statement: “Pharmacy benefit managers (PBMs) advocate on behalf of Pennsylvania’s consumers and health plan sponsors by negotiating with drug manufacturers and
Unlocking an Affordable Future Unlocking an Affordable Future NEWSROOM Alex Brill: Trends In The US Insulin Market: New Prices, New Players, New Dynamics NEWSROOM Alex Brill: Trends In The US Insulin Market: New Prices, New Players, New Dynamics Stop The
Pharmacy Benefit Managers reduce prescription drug costs for patients and use innovative technology to help patients get their prescriptions and lead healthier lives.
Asthma is a long-term respiratory disease that causes inflammation and swelling in the airways. Twenty-Five million Americans, 1 in every 13 people, live with asthma, a number that has been steadily increasing since the 1980s. PBMs want patients to stay
(Washington, D.C.) — As drugstore lobbyists descend on Albany today, it is important to highlight how pharmacy benefit managers (PBMs) advocate for consumers and health plan sponsors in the fight to keep prescription drugs accessible and affordable. It is equally
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today released a new report, “Drug Manufacturer Strategies for Keeping Drug Costs High,” on pharmaceutical industry pricing tactics that increase prescription drug costs for patients. The report, conducted by the research firm Visante,
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on the Senate Finance Committee hearing, “Drug Pricing in America: A Prescription for Change, Part II:” “We commend the Senate Finance Committee for
(Washington, D.C.) — Pharmaceutical Care Management Association President and CEO JC Scott issued the following statement on the House Judiciary Committee’s markup of H.R. 2883, the “Stop Stalling Access to Affordable Medications”; H.R. 2891, the “Preserve Access to Affordable Generics
©2024 PCMA. All Rights Reserved.
